110 related articles for article (PubMed ID: 35022351)
21. Electrophysiological and neuroimaging tools to evaluate neurological symptoms, manifestations, and complications in patients with long COVID-19.
Luvizutto GJ; Bazan R
Neurol Neurochir Pol; 2023; 57(1):8-10. PubMed ID: 36515147
[No Abstract] [Full Text] [Related]
22. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
[TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies.
Chong ZZ; Souayah N
Curr Med Chem; 2022; 29(12):2051-2074. PubMed ID: 33970839
[TBL] [Abstract][Full Text] [Related]
24. Neuropathogenesis of acute coronavirus disease 2019.
Farhadian SF; Seilhean D; Spudich S
Curr Opin Neurol; 2021 Jun; 34(3):417-422. PubMed ID: 33852526
[TBL] [Abstract][Full Text] [Related]
25. Neurological manifestations of COVID-19: with emphasis on Iranian patients.
Aslan C; Nikfarjam S; Asadzadeh M; Jafari R
J Neurovirol; 2021 Apr; 27(2):217-227. PubMed ID: 33710597
[TBL] [Abstract][Full Text] [Related]
26. Potential neurological manifestations of COVID-19: a narrative review.
Pergolizzi JV; Raffa RB; Varrassi G; Magnusson P; LeQuang JA; Paladini A; Taylor R; Wollmuth C; Breve F; Chopra M; Nalamasu R; Christo PJ;
Postgrad Med; 2022 May; 134(4):395-405. PubMed ID: 33089707
[TBL] [Abstract][Full Text] [Related]
27. Miller-Fisher syndrome after COVID-19: neurochemical markers as an early sign of nervous system involvement.
Senel M; Abu-Rumeileh S; Michel D; Garibashvili T; Althaus K; Kassubek J; Otto M
Eur J Neurol; 2020 Nov; 27(11):2378-2380. PubMed ID: 32781484
[TBL] [Abstract][Full Text] [Related]
28. Long-COVID: neurological manifestations and management.
Williams S; Wynford-Thomas R; Robertson NP
J Neurol; 2021 Dec; 268(12):4915-4917. PubMed ID: 34674007
[No Abstract] [Full Text] [Related]
29. Potential mechanism of SARS-CoV-2-associated central and peripheral nervous system impairment.
Zhang Y; Chen X; Jia L; Zhang Y
Acta Neurol Scand; 2022 Sep; 146(3):225-236. PubMed ID: 35699161
[TBL] [Abstract][Full Text] [Related]
30. Call for correction: Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis.
Hagiya H; Otsuka Y; Otsuka F
J Neurol Sci; 2022 May; 436():120232. PubMed ID: 35339066
[No Abstract] [Full Text] [Related]
31. SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease-(COVID-19).
Payus AO; Liew Sat Lin C; Mohd Noh M; Jeffree MS; Ali RA
Bosn J Basic Med Sci; 2020 Aug; 20(3):283-292. PubMed ID: 32530389
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article.
Taher T; Sheikh AB; Anwar F; Khosa F
Acta Neurol Belg; 2021 Apr; 121(2):331-339. PubMed ID: 33464546
[TBL] [Abstract][Full Text] [Related]
33. Severe neurological complications in critically ill COVID-19 patients.
Notz Q; Lotz C; Herrmann J; Vogt M; Schlesinger T; Kredel M; Muellges W; Weismann D; Westermaier T; Meybohm P; Kranke P
J Neurol; 2021 May; 268(5):1576-1579. PubMed ID: 32797297
[No Abstract] [Full Text] [Related]
34. Comprehensive Review on Neuro-COVID-19 Pathophysiology and Clinical Consequences.
Jafari Khaljiri H; Jamalkhah M; Amini Harandi A; Pakdaman H; Moradi M; Mowla A
Neurotox Res; 2021 Oct; 39(5):1613-1629. PubMed ID: 34169404
[TBL] [Abstract][Full Text] [Related]
35. COVID-19 and Neurological Impairment: Hypothalamic Circuits and Beyond.
Mussa BM; Srivastava A; Verberne AJM
Viruses; 2021 Mar; 13(3):. PubMed ID: 33802995
[TBL] [Abstract][Full Text] [Related]
36. Neurological manifestations and pathogenic mechanisms of COVID-19.
Galea M; Agius M; Vassallo N
Neurol Res; 2022 Jul; 44(7):571-582. PubMed ID: 34986754
[TBL] [Abstract][Full Text] [Related]
37. Neurological Presentations of COVID-19: Characteristic Features in a Case Series of Hospitalized Patients from Abu Dhabi, UAE.
Deeb A; Kumar PC; Sakrani N; Trehan RK; Papinenei VR
Biomed Res Int; 2021; 2021():5822259. PubMed ID: 34423037
[TBL] [Abstract][Full Text] [Related]
38. Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature.
Siracusa L; Cascio A; Giordano S; Medaglia AA; Restivo GA; Pirrone I; Saia GF; Collura F; Colomba C
Ital J Pediatr; 2021 Jun; 47(1):123. PubMed ID: 34078441
[TBL] [Abstract][Full Text] [Related]
39. [Neurological Manifestations and COVID-19].
Costa A; Silva-Pinto A
Acta Med Port; 2020 Dec; 33(12):787-788. PubMed ID: 33159725
[No Abstract] [Full Text] [Related]
40. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
Harapan BN; Yoo HJ
J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
